PE targets opportunities in nutraceuticals: 7 deals
Butterfly Equity, Gryphon Investors, Frontenac and Wise Equity are targeting platforms in the nutraceuticals sector. The post PE targets opportunities in nutraceuticals: 7 deals appeared first on PE Hub .
Butterfly Equity, Gryphon Investors, Frontenac and Wise Equity are targeting platforms in the nutraceuticals sector. The post PE targets opportunities in nutraceuticals: 7 deals appeared first on PE Hub .
BELLINGS Intelligence Score: 15
Why it matters
This is a routine private equity sector activity involving several deals in nutraceuticals, reflecting ongoing investment trends but not altering market structure or credit conditions materially.
Sources
PE Hub
PE targets opportunities in nutraceuticals: 7 deals
Butterfly Equity, Gryphon Investors, Frontenac and Wise Equity are targeting platforms in the nutraceuticals sector. The post PE targets opportunities in nutraceuticals: 7 deals appeared first on PE Hub .